Skip to main content
CAMP logo
CAMP
(NASDAQ)
Camp4 Therapeutics Corporation
$3.92-- (--)
Loading... - Market loading

Camp4 Therapeutics (CAMP) Stock Price & Financial Analysis

Camp4 Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.74 - $4.21
52-Week High$7.75
52-Week Low$1.32
Open$4.10
Volume238.78K
Average Volume (3M)126.19K
Market Cap227.06M
Shares Outstanding57.92M
Price to Sales (P/S)57.72
Price to Book (P/B)7.35
EV/EBITDA-2.56
Revenue (TTM)3.93M
Net Income (TTM)-86.30M
Free Cash Flow (TTM)-28.36M
EPS (TTM)$-2.20
Profit Margin-2193.72%
Operating Margin-1335.18%
Return on Equity (ROE)-279.27%
Debt to Equity0.07
50-Day MA$4.27
200-Day MA$4.30
52-Week Change151.28%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Camp4 Therapeutics

What is the current stock price for CAMP?

As of the latest trading session, CAMP stock trades at $3.92. The 52-week range is $1.32–$7.75, with a day range of $3.74–$4.21.

What is the P/E ratio for CAMP?

The P/E ratio (Price-to-Earnings) for CAMP is shown in the Key Statistics section. This valuation metric helps compare Camp4 Therapeutics Corporation to industry peers.

Does CAMP pay dividends?

Camp4 Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CAMP?

Based on 8 analysts, the consensus for CAMP is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CAMP?

Camp4 Therapeutics's market capitalization is $227.1M, classifying it as a micro-cap company. Camp4 Therapeutics operates in the Healthcare sector within the Biotechnology industry.